A derma roller for hair loss does appear to work, but not on its own. Every randomised trial in this area gave microneedling alongside minoxidil, and compared it against minoxidil alone. The combination beats the drug by itself, consistently and by a wide margin. What has never been tested to that standard is rolling with nothing else.
Which makes almost every article on this subject subtly wrong, including the ones quoting the right study.
The Short Version
- The famous trial found 91.4 new hairs per cm² with microneedling against 22.2 with minoxidil alone. Both groups were using minoxidil.
- Microneedling plus a topical treatment consistently outperforms the topical treatment alone across multiple trials and meta-analyses.
- A 2025 meta-analysis of 12 trials found needle depth made no significant difference to hair count. Nor did device type. Nor did treatment duration.
- Which means the needle-size charts sold with every roller are measuring something the research could not detect.
- The mechanism is two-part: growth factor release from controlled injury, and substantially increased absorption of whatever you apply afterwards.
- Results are not permanent. One follow-up found most participants losing some regrowth within six months of stopping.
- The overall quality of the evidence is described by reviewers as relatively low, which is worth knowing before spending money.
What is micro-needling?
Microneedling means creating controlled micro-injuries in the skin using a device covered in fine needles, either a roller or a powered pen. On the scalp it is used for hair loss, where the healing response releases growth factors and the resulting micro-channels let topical treatments penetrate further. Needle depths in hair loss trials have ranged from 0.5 mm to 1.5 mm. “Dermarolling” and “microneedling” describe the same thing.
What the derma roller for hair loss trials actually found
The study everyone quotes is Dhurat and colleagues, published in the International Journal of Trichology in 2013. It randomised 100 men with androgenetic alopecia into two groups for 12 weeks.
The microneedling group received weekly 1.5 mm microneedling plus minoxidil. The control group received minoxidil alone.
Mean hair count rose by 91.4 hairs per cm² in the microneedling group against 22.2 in the minoxidil-only group. Forty-one of 50 men in the microneedling group reported more than 50% improvement, against 2 of 45 in the minoxidil group.
That is a genuinely striking effect size and it is why this trial launched an industry.
The detail that changes what it means
Both arms were taking minoxidil. The trial did not test microneedling against nothing. It tested minoxidil plus microneedling against minoxidil.
So the correct reading is that microneedling is a powerful adjunct. It is not evidence that rolling your scalp produces hair on its own, and the difference matters enormously if you were planning to buy a roller and skip the drug.
This is not a fringe criticism. Every one of the 12 randomised trials in the 2025 meta-analysis paired microneedling with minoxidil. Rolling by itself has simply not been studied at that standard.
The trial did not test microneedling against nothing. It tested minoxidil plus microneedling against minoxidil.
Does the combination genuinely work?
es, and this is the part where the evidence is reasonably solid.
A 2024 systematic review and meta-analysis in the Journal of Cosmetic Dermatology pooled randomised trials of combined microneedling therapy for androgenetic alopecia and found the combination superior to topical treatment alone. A 2019 meta-analysis in the Journal of the American Academy of Dermatology reached the same conclusion across several randomised trials.
A broader 2021 review found that microneedling improved hair loss parameters across a range of hair loss types, devices, depths, session frequencies and combination therapies.
The direction of the finding is consistent. What varies is the size of the effect and the quality of the studies, which we come back to below.
Why does it work?
Two mechanisms, both plausible and both supported.
Growth factor release
Controlled micro-injury triggers a wound healing response, releasing platelet-derived growth factor, epidermal growth factor and activators of the Wnt signalling pathway at the site. These are involved in hair follicle proliferation, and the Wnt pathway in particular has been examined directly in at least one randomised trial.
The important nuance is that the healing produces the benefit, not the injury. Rolling again before the tissue has finished repairing interrupts the process you are trying to trigger.
Increased drug absorption
The micro-channels created in the stratum corneum let topical treatments penetrate considerably further. Estimates of the increase in minoxidil delivery vary widely across sources, from roughly fourfold upward depending on needle depth and molecule size.
This is likely where most of the observed benefit comes from, and it explains why every trial pairs the two. The roller is partly a drug delivery device.
It also explains a practical point that gets ignored: applying minoxidil onto a freshly needled scalp increases absorption of everything, including the propylene glycol that causes irritation for many users. Most protocols advise leaving a gap between rolling and applying.
Does needle depth matter?
The evidence says no, which contradicts essentially every guide you will read.
Every roller sold comes with a depth chart. 0.25 mm for absorption. 0.5 mm for growth. 1.5 mm for serious cases. It is presented as settled.
A 2025 meta-analysis of 12 randomised trials ran a subgroup analysis on exactly this question and found no significant effect of needle depth on hair count, comparing depths of 1 mm or less against depths greater than 1 mm. Treatment duration made no significant difference either. Nor did device type: rolling and powered devices performed comparably.
Three of the variables people agonise over, and the pooled data could not detect an effect from any of them.
There is a sensible practical reading of this. If deeper needles are not measurably better, the shorter depths are the rational choice, because they hurt less, heal faster, carry lower infection risk and can be used more often. The marketing has been pushing people toward longer needles on the basis of an effect the research has not found.
How long do the results last?
This is the least discussed part of the evidence and the most useful for deciding whether to start.
Follow-up data is limited and mixed. Dhurat followed participants eight months after treatment ended and reported that the combined microneedling group sustained their response. A separate trial by Bao and colleagues returned to participants six months after the study finished and found 20% had further increases in hair density, 70% had lost a small amount of hair, and 10% had lost all of their new hair.
Another trial followed up by telephone and found most patients reported no relapse, though 12 said their hair loss had restarted.
Androgenetic alopecia is a progressive genetic condition. Nothing currently available cures it, and treatments manage it for as long as they continue. Microneedling appears to be no exception, and the honest expectation is maintenance rather than a course of treatment with a permanent result.
What the evidence cannot tell you
Four limits, and they matter more here than in most of what we cover.
- The overall quality is not high. A 2021 review put it plainly: while evidence suggests microneedling might improve hair loss, the clinical data are of relatively low quality. Small samples, short durations, varied protocols and inconsistent outcome measures throughout.
- Solo use is untested. There is no good evidence that a derma roller for hair loss works without a topical treatment, because no randomised trial has tested it that way. Absence of evidence is not evidence of absence, but it is also not a reason to assume it works.
- Trials are short. Most run 12 weeks. Hair growth cycles take months, and androgenetic alopecia plays out over decades. A 12-week result tells you very little about year three.
- Clinic protocols are not home protocols. Much of the trial data comes from trained practitioners using sterile technique at 1.5 mm in clinical settings. A home roller used without proper cleaning carries an infection risk that the trials were designed to eliminate.
Three of the variables people agonise over, and the pooled data could not detect an effect from any of them.
What to do with this
Five things, ordered by how strongly the evidence supports them.
1. Find out what is causing the loss first
Androgenetic alopecia, telogen effluvium, thyroid problems and iron deficiency produce different patterns and respond to entirely different things. Microneedling has been studied mainly in androgenetic alopecia. Buying a roller before knowing which condition you have is skipping the only step that determines whether any of this applies to you.
2. Treat it as an addition, not a replacement
The evidence supports microneedling alongside a topical treatment. If you are not going to use a topical, the research base for what you are doing is essentially empty.
3. Stop optimising needle length
The pooled data found no significant effect of depth on hair count. Shorter needles are less painful, heal faster and carry lower risk. There is no evidence-based reason to escalate.
4. Leave time between rolling and applying
Increased absorption applies to irritants as well as active ingredients. Most protocols suggest waiting rather than applying minoxidil to a freshly needled scalp, and the trials that produced these results generally did not apply the drug immediately after.
5. Keep the device clean
The trials used sterile technique. Infection risk at home comes almost entirely from poor cleaning and from sharing devices. Replace rollers regularly, since needles blunt with use and blunt needles tear rather than puncture.
Common questions
What to take from this
A derma roller for hair loss is one of the few budget interventions in this space with real randomised evidence behind it. That is worth saying clearly, because most of what is sold for hair has none.
What the evidence supports is narrower than what is advertised. It supports microneedling as an addition to a topical treatment. It does not support rolling alone, it does not support the needle-depth charts, and it does not support the idea that results persist once you stop.
Which still leaves a cheap device with a genuine effect, provided you are honest about what it is doing. It is mostly helping a drug work better, and that is a perfectly good reason to use one.
For the same evidence-first treatment of the rest of your routine, see our guide to the four skincare ingredients with real evidence, or browse the full Grooming section.
References
- Dhurat, R., Sukesh, M., Avhad, G., Dandale, A., Pal, A., & Pund, P. (2013). A randomised evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. International Journal of Trichology, 5(1), 6-11. [NO LINK]
- Pei, S., et al. (2024). Efficacy and safety of combined microneedling therapy for androgenic alopecia: a systematic review and meta-analysis of randomized clinical trials. Journal of Cosmetic Dermatology. Publisher
- English, R. S., et al. (2021). A review of the microneedling literature for hair loss. Dermatology and Therapy. Open access
- Meta-analysis of 12 randomised controlled trials on microneedling for androgenetic alopecia, including subgroup analyses of needle depth, device type and treatment duration (2025). Archives of Dermatological Research. [NO LINK]
- Bao, L., et al. (2022). Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males. Journal of Dermatological Treatment, 33(1), 483-493. [NO LINK]
- Issa, N., & Hafez, V. (2019). Meta-analysis on microneedling for androgenetic alopecia. Journal of the American Academy of Dermatology. [NO LINK]
This article summarizes published research and is not medical advice. Hair loss has many causes and they respond to different treatments. See a doctor or dermatologist for a diagnosis before starting anything.